{
  "id": "SCR-LIP-000616",
  "statement": "Fibromyalgia is frequently reported to co-occur with lipedema in cross-sectional studies, although reported frequencies vary widely between samples.",
  "claim_type": "clinical_association",
  "context": {
    "population": "adult women with fibromyalgia (ACR 2016, n=100)",
    "condition": "lipedema",
    "exposure": "fibromyalgia",
    "comparator": "fibromyalgia patients without lipedema",
    "outcome": "lipedema prevalence and risk factors",
    "scope": "prevalence within a fibromyalgia population"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "moderate",
  "evidence": [
    {
      "ref": "DOI:10.1177/02683555251321042",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": 100,
      "risk_of_bias": "moderate",
      "year": 2025,
      "amato_authored": false,
      "note": "Gunaydin; lipedema in 50%; pain correlated with widespread pain r=0.62",
      "title": "Lipedema awareness in fibromyalgia",
      "authors": "Bolkan Günaydın et al.",
      "journal": "Phlebology: The Journal of Venous Disease",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article directly reports lipedema in 50% of fibromyalgia patients (n=100 women meeting ACR 2016 criteria), with long fibromyalgia diagnosis time and low age at menarche as significant r",
        "date": "2026-06-10"
      },
      "quote": "Lipedema was observed in 50% of the patients (58% Stage 1 lipedema). In the lipedema group, age, duration of fibromyalgia diagnosis, hematoma tendency/presence of telangiectasias (for all; p < .001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Among 100 women meeting fibromyalgia criteria, lipedema was found in 50% (58% stage 1); longer fibromyalgia diagnostic delay associated with lipedema.",
      "from_claims": [
        "SCR-LIP-000021"
      ]
    },
    {
      "ref": "DOI:10.1089/lrb.2023.0038",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2024,
      "amato_authored": false,
      "note": "The study directly measures fibromyalgia prevalence in a lipedema population using validated diagnostic criteria (ACR 2016), finding a 35% comorbidity rate. Limitations include self-reported data via online survey and potential selection bi",
      "title": "Prevalence of Fibromyalgia Syndrome in Women with Lipedema and Its Effect on Anxiety, Depression, and Quality of Life",
      "authors": "Cagliyan Turk et al.",
      "journal": "Lymphatic Research and Biology",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article directly reports that 124/354 (35%) of lipedema patients met ACR 2016 FMS criteria, and that those with FMS had significantly higher anxiety scores (13.11 vs 9.87), depression scores (10.23 vs 8.26), and lower SF-12 physical and",
        "date": "2026-06-10"
      },
      "quote": "One hundred twenty-four patients (35%) satisfied FMS criteria.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In an online survey of 354 women with lipedema, 35% (124/354) met ACR 2016 fibromyalgia criteria; those with fibromyalgia had higher anxiety, depression and worse quality of life.",
      "from_claims": [
        "SCR-LIP-000104"
      ]
    },
    {
      "ref": "DOI:10.2147/jpr.s315736",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2021,
      "amato_authored": false,
      "note": "Direct empirical comparison of fibromyalgia and lipedema cohorts with validated instruments; cross-sectional design limits causal inference, but the 34% comorbidity rate and phenotypic overlap data directly address the association between l",
      "title": "Common and Contrasting Characteristics of the Chronic Soft-Tissue Pain Conditions Fibromyalgia and Lipedema",
      "authors": "Angst et al.",
      "journal": "Journal of Pain Research",
      "grade": "moderate",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "Human review: this source corroborates the fibromyalgia–lipedema overlap with its own cohort (n=112); the statement's 354/124 figures are from a sibling source (integrity clean). Accepted.",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "34% das mulheres com lipedema preenchem critérios ACR 2016 para fibromialgia comórbida",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "34% of women with lipedema met ACR 2016 criteria for comorbid fibromyalgia; comparison of fibromyalgia and lipedema cohorts showed phenotypic overlap.",
      "from_claims": [
        "SCR-LIP-000104"
      ]
    },
    {
      "ref": "DOI:10.47582/jompac.1301253",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "moderate",
      "year": 2023,
      "amato_authored": false,
      "note": "The study directly quantifies the co-occurrence of fibromyalgia in lipedema patients (39.6% met ACR 2016 criteria) and characterizes pain/QoL effects, with results converging with prior studies (34%, 50%). It is observational and unadjusted",
      "title": "Comorbidity of lipedema and fibromyalgia; effects on disease severity, pain and health-related quality of life",
      "authors": "ÇAKIT et al.",
      "journal": "Journal of Medicine and Palliative Care",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article abstract directly reports 39.6% (21/53) of lipedema patients met ACR 2016 FM criteria, median VAS 60 for comorbid group vs 27 for lipedema-only (p<0.001), and SF-36 scores worse across all 8 components in the comorbid group comp",
        "date": "2026-06-10"
      },
      "quote": "39,6% (21/53) das pacientes com lipedema preencheram critérios ACR 2016 de FM",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "39.6% (21/53) of lipedema patients met ACR 2016 fibromyalgia criteria; the comorbid subgroup had higher pain (median VAS 60 vs 27, p<0.001) and worse SF-36 scores in all domains.",
      "from_claims": [
        "SCR-LIP-000290"
      ]
    },
    {
      "ref": "DOI:10.1038/ijo.2016.205",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2017,
      "amato_authored": false,
      "note": "The article documents fibromyalgia, migraines, and pain scores as comorbidities in lipedema patients, providing direct prevalence data bearing on the question. However, prevalences are crude (unadjusted) and the primary focus is differentia",
      "title": "Differentiating lipedema and Dercum’s disease",
      "authors": "Beltran & Herbst",
      "journal": "International Journal of Obesity",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article explicitly reports fibromyalgia prevalence of 28% in DD vs 10% in lipedema (P=0.0003), migraines 21% in DD vs 7% in lipedema (P=0.005), and pain score of 4±2.5 for lipedema on a",
        "date": "2026-06-10"
      },
      "quote": "Fibromialgia: DD 28% vs lipedema 10% (P=0,0003). Enxaquecas: DD 21% vs lipedema 7% (P=0,005).",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Fibromyalgia was reported in 10% of lipedema patients versus 28% in Dercum's disease (P=0.0003); crude, unadjusted prevalences.",
      "from_claims": [
        "SCR-LIP-000291"
      ]
    },
    {
      "ref": "DOI:10.1007/s13555-018-0241-6",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2018,
      "amato_authored": false,
      "note": "Cross-sectional survey reports fibromyalgia as a comorbidity and high pain prevalence among lipedema patients, but only crude self-reported counts without adjusted association analysis or control comparison for fibromyalgia specifically.",
      "title": "Exploration of Patient Characteristics and Quality of Life in Patients with Lipoedema Using a Survey",
      "authors": "Romeijn et al.",
      "journal": "Dermatology and Therapy",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article confirms all specifics in the statement: 88.3% pain prevalence, mean NRS 4.2, fibromyalgia as a comorbidity (n=14), and comorbidities associated with significantly reduced quali",
        "date": "2026-06-10"
      },
      "quote": "Comorbidades relatadas em 92 casos (56,4–57,1%); mais frequentes: doença cardíaca (n=35), doença da tireoide (n=19), fibromialgia (n=14), diabetes mellitus (n=9), doença intestinal (n=8), asma (n=8), linfedema (n=5)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In a survey of lipedema patients, fibromyalgia was among the most frequently reported comorbidities (n=14); comorbidities were associated with reduced quality of life.",
      "from_claims": [
        "SCR-LIP-000295"
      ]
    },
    {
      "title": "Lipedema as a Syndrome of Adipose",
      "ref": "DOI:10.20944/preprints202605.1114.v1",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "quote": "a 35–40% comorbidity with fibromyalgia, a 1.42 relative risk for ADHD",
      "extraction_confidence": "high",
      "note": "Article reports a 35–40% comorbidity of lipedema with fibromyalgia and chronic neuropathic pain features, supporting the affirmative association, though it is a proposed framework/review citing reported observations.",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly states a '35–40% comorbidity with fibromyalgia' and proposes histaminergic peripheral sensitization generating neuropathic pain in gluteofemoral white adipose tissue (gfWAT), directly supporting the statement.",
        "date": "2026-06-28"
      },
      "stance_in_source_claim": "supporting",
      "finding": "A proposed mechanistic framework cites a 35-40% comorbidity of lipedema with fibromyalgia.",
      "from_claims": [
        "SCR-LIP-000402"
      ],
      "secondary_of": "DOI:10.1089/lrb.2023.0038"
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [
    {
      "name": "Alexandre C. M. Amato",
      "orcid": "0000-0003-4008-4029",
      "role": "lead_curator"
    }
  ],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000021",
    "SCR-LIP-000104",
    "SCR-LIP-000290",
    "SCR-LIP-000291",
    "SCR-LIP-000295",
    "SCR-LIP-000402"
  ],
  "questions_consolidated": [
    "SQ-LIP-000008"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00065",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000008"
    }
  ],
  "statement_pt": "A fibromialgia é frequentemente relatada como coocorrente com o lipedema em estudos transversais, embora as frequências relatadas variem amplamente entre as amostras.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000008",
      "role": "supporting",
      "question": "Is lipedema associated with fibromyalgia and other chronic-pain conditions?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000008.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000616.html"
}